Frank–ter Haar syndrome

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Frank–ter Haar syndrome (FTHS), also known as Ter Haar syndrome, is a rare disease characterized by abnormalities that affect bone, heart, and eye development. Children born with the disease usually die very young.

History[edit]

In 1973, researchers led by Dr. Yitzchak Frank, most recently at Mount Sinai Hospital in New York, described an 18-month-old Bedouin girl, born to consanguineous parents, who presented with enlarged corneas, multiple bone abnormalities, and developmental delay.[1] In 1982, Dutch pediatrician Dr. Ben ter Haar reported on three similar patients thought to have Melnick–Needles syndrome.[2] Over the next twenty years, several more similar cases were identified and eventually attributed to a new disorder, now called Frank–ter Haar syndrome. FTHS is distinguished from other similar conditions based on its pattern of inheritance and association with congenital glaucoma and congenital heart disease.[3]

Clinical presentations[edit]

The primary characteristics of FTHS are brachycephaly (flat head), wide fontanelle (soft spot on a baby’s head), prominent forehead, hypertelorism (abnormally wide distance between the eyes), prominent eyes, macrocornea (large corneas), full cheeks, small chin, bowing of the long bones in the arms or legs, and finger deformities. Protruding, simple ears and a prominent coccyx (tailbone) are also regarded as important diagnostic signs of FTHS.[3]

Genetic basis[edit]

Genetic mapping in several families with FTHS linked the disease to an inherited mutation in the gene that codes for the protein Tks4.[4] Tks4 was already known for its role in the formation of cellular projections known as podosomes, which allow cells to migrate.[5] A mouse model that lacks the Tks4 gene shows all the symptoms of FTHS confirmed the hypothesis that Tks4 mutation is responsible for the disease.[4]

Treatment[edit]

There is no treatment for FTHS, though identification of TKS4 mutation as a causative factor may eventually provide new opportunities for neonatal screening in high-risk families.

References[edit]

  1. ^ Frank Y, Ziprkowski M, Romano A, et al. (June 1973). "Megalocornea associated with multiple skeletal anomalies: a new genetic syndrome?". Journal de génétique humaine 21 (2): 67–72. PMID 4805907. 
  2. ^ ter Haar B, Hamel B, Hendriks J, de Jager J (December 1982). "Melnick-Needles syndrome: indication for an autosomal recessive form". American Journal of Medical Genetics 13 (4): 469–77. doi:10.1002/ajmg.1320130418. PMID 7158646. 
  3. ^ a b Maas SM, Kayserili H, Lam J, Apak MY, Hennekam RC (December 2004). "Further delineation of Frank-ter Haar syndrome". American Journal of Medical Genetics. Part a 131 (2): 127–33. doi:10.1002/ajmg.a.30244. PMID 15523657. 
  4. ^ a b Iqbal Z, Cejudo-Martin P, de Brouwer A, et al. (February 2010). "Disruption of the podosome adaptor protein Tks4 (SH3PXD2B) causes the skeletal dysplasia, eye, and cardiac abnormalities of Frank-Ter Haar Syndrome". American Journal of Human Genetics 86 (2): 254–61. doi:10.1016/j.ajhg.2010.01.009. PMC 2820172. PMID 20137777. 
  5. ^ Buschman MD, Bromann PA, Cejudo-Martin P, Wen F, Pass I, Courtneidge SA (March 2009). "The novel adaptor protein Tks4 (SH3PXD2B) is required for functional podosome formation". Molecular Biology of the Cell 20 (5): 1302–11. doi:10.1091/mbc.E08-09-0949. PMC 2649273. PMID 19144821. 

External links[edit]